What Are The Chances Of Sana Biotechnology Inc (NASDAQ: SANA) Becoming A Clear Buy?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Stocks Info

As a NASDAQ listed company, SANA falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Sana Biotechnology Inc is $2.23B. A total of 1.27 million shares were traded on the day, compared to an average of 3.48M shares.

In the most recent transaction, Yang Patrick Y sold 25,000 shares of SANA for 9.45 per share on Mar 08 ’24. After the transaction, the Director now owns 149,250 company shares. In a previous transaction on Feb 08 ’24, NELSEN ROBERT bought 1,818,181 shares at 5.50 per share. SANA shares that Director owns now total 12,446,022.

Among the insiders who bought shares, ARCH Venture Fund X, L.P. acquired of 1,818,181 shares on Feb 08 ’24 at a per-share price of $5.50. This resulted in the 10% Owner holding 12,446,022 shares of SANA after the transaction. In another insider transaction, CRANDELL KEITH bought 1,818,181 shares at $5.50 per share on Feb 08 ’24. Company shares held by the 10% Owner now total 12,446,022.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, SANA has a high of $12.00 and a low of $2.74.

As of this writing, SANA has an earnings estimate of -$0.32 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.25 per share and a lower estimate of -$0.43. The company reported an EPS of $0.02 in the last quarter, which was 104.40% higher than expectations of -$0.45.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. SANA’s latest balance sheet shows that the firm has $551.00M in Cash & Short Term Investments as of fiscal 2021. There were $110.94M in debt and $99.23M in liabilities at the time. Its Book Value Per Share was $1.45, while its Total Shareholder’s Equity was $728.50M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SANA is Buy with a score of 4.25.

Most Popular

Related Posts